Pharma manufacturing needs U.S. space—now
New tariffs on branded pharmaceuticals are pushing production onshore. Our Class A industrial buildings in the Southeast United States are ready.
The pressure on pharma
Tariffs on branded medications and tightening drug-pricing policies are reshaping cost structures. Import dependence increases volatility and risk.
Onshoring manufacturing is the fastest path to cost control, supply chain stability, and speed-to-market.
Avoid tariff exposure
Produce in the U.S. to reduce landed costs and price volatility.
Stabilize supply
Shorten logistics, secure inputs, and improve predictability.
Accelerate scale
Expansion-ready buildings reduce time to production.
Class A industrial buildings designed for manufacturing
Available buildings
Class A single-tenant
~150,000–160,000 SF options
Expansion-ready, power capacity, manufacturing-friendly layout
Multiple Class A buildings
100,000–300,000 SF
Established manufacturing base, strong labor pool
Why the Southeast
Skilled talent
Access engineering and technical programs across the region's universities and technical colleges.
Central reach
Proximity to suppliers and customers across the Southeast.
Cost advantage
Labor and occupancy savings vs. coastal markets.